DiaCarta Lands $8,000,000 Series A Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    3535 Breakwater Ave. Hayward, CA 94545 USA
  • Company Description
    DiaCarta provides precise cancer molecular tests including NRAS, EGFR and KRAS mutation test kits, PCR ready lysis kit, HPV E6/E7 mRNA test kits for cervical and head-neck cancer, cancer biomarker gene expression detection kits and superfast master mix.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from Series A financing will be used to expand the product portfolio and support global commercialization.
  • M&A Terms
  • Venture Investor

Trending on Xconomy